Adam Kaplin
Director/Board Member chez Cody Unser First Step Foundation
Fortune : 220 000 $ au 31/03/2024
Profil
Adam Kaplin is the founder of MIRA Pharmaceuticals, Inc., which was founded in 2020.
He held the title of President & Chief Science Officer from 2022 to 2024.
Dr. Kaplin is also currently working at The Johns Hopkins University as the Director of the Johns Hopkins Ketamine Clinic since 2002.
Additionally, he is the Director of Cody Unser First Step Foundation since 2005.
Previously, Dr. Kaplin worked as the Chief Scientific Officer at MyMD Pharmaceuticals, Inc. from 2020 to 2024.
Dr. Kaplin obtained his doctorate degree from The Johns Hopkins University in 1996 and his undergraduate degree from Yale University in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 03/08/2023 | 200 000 ( 1,35% ) | 220 000 $ | 31/03/2024 | |
| 29/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Adam Kaplin
| Sociétés | Poste | Début |
|---|---|---|
| The Johns Hopkins University | Corporate Officer/Principal | 01/01/2002 |
| Cody Unser First Step Foundation | Director/Board Member | 01/01/2005 |
Anciens postes connus de Adam Kaplin
| Sociétés | Poste | Fin |
|---|---|---|
| MYMD PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15/04/2024 |
| MIRA PHARMACEUTICALS, INC. | Founder | 07/03/2024 |
Formation de Adam Kaplin
| The Johns Hopkins University | Doctorate Degree |
| Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MYMD PHARMACEUTICALS, INC. | Health Technology |
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Cody Unser First Step Foundation |
